Qualcomm Life, Inc., a subsidiary of Qualcomm Technologies, Inc. (QTI), today announced the availability of its wireless healthcare services offering in Europe.
Qualcomm Life’s 2net Platform and Hub are designed to enable medical device manufacturers and service providers to wirelessly connect their medical devices via a secure, cloud-based solution so that biometric information is easily accessible by device users, their healthcare providers and caregivers.
According to Qualcomm, the 2net Platform and Hub are each individually certified as Class I Medical Devices in Europe, and FDA listed as a Medical Device Data System (MDDS) in the U.S.
Mobile health holds significant potential in Europe to defray healthcare costs and increase the quality and quantity of care, helping to address anticipated shortages of qualified healthcare professionals, suggests Qualcomm.
Globally, according to Qualcomm, Europe has the highest burden of chronic disease, and the continued increase in prevalence is considered an epidemic by the World Health Organization (WHO), which estimates chronic diseases will claim the lives of 52 million people in the European region by 2030.